Photo

Clarity, Quality and Efficiency

Unveiled in April 2026, Brenntag's biopharma brand, Byphar, is aimed at companies in the biopharmaceutical industry. Joakim Rehné, President of Brenntag Pharma EMEA, explains the strategy behind the new brand.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

  • 16September

    16.09.2026 - 18.09.2026

    London, UK

    11th World Adhesive & Sealant Conference and EXPO

    World Adhesives Conference 2026

    The World Adhesives Conference, taking place only every four years, is the most important event for all stakeholders involved in the adhesive and sealant sector and attracts well over a thousand delegates from all continents. The visitors are adhesive and sealant producers, raw
    material suppliers, service providers, scientists and downstream
    users.

  • 17September

    17.09.2026 - 17.09.2026

    Virtual

    Free Virtual Event

    Batteries and Hydrogen: Competitors or Partners?

    Next-generation batteries and hydrogen: competitors – or the key to industrial decarbonization? See where energy storage is headed on Sept 17.

  • 22September

    22.09.2026 - 24.09.2026

    Siegburg/Cologne, Germany

    The Future Sustainable Chemical and Materials Industry will be Based Entirely on Biomass, CO₂ and Recycling

    Renewable Materials Conference 2026

    September 22 – 24, 2026 | The international meeting place for the chemical, the plastics and materials industries. Taking place in Siegburg/Cologne, Germany, the RMC presents solutions and innovations for replacing fossil carbon with biomass, CO2 utilization and recycling.

  • 5October

    05.10.2026 - 08.10.2026

    Vienna, Austria

    Agility, Resilience, and Reinvention for a Dynamic Future

    EPCA 60

    October 5 – 8, 2025 | Join us at the European Petrochemical Association (EPCA)’s 60th Annual Meeting, where industry leaders will chart the path forward. Engage with over 2,500 professionals from 500+ companies, gain insights from global experts, and help shape a future where Europe’s petrochemical industry remains competitive, secure, and at the forefront of global innovation.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Popular Articles

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

CHEManager International Media Kit 2026

CHEManager International Media Kit 2026

Compelling solutions through strategic partnerships

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

Media Kit

Photo

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.